TY  - JOUR
AU  - Moreno-Delgado, David
AU  - Puigdellívol, Mar
AU  - Moreno, Moreno
AU  - Rodríguez-Ruiz, Mar
AU  - Botta, Joaquín
AU  - Gasperini, Paola
AU  - Chiarlone, Anna
AU  - Howell, Lesley A.
AU  - Scarselli, Marco
AU  - Casadó, Vicent
AU  - Cortés, Antoni
AU  - Ferré, Sergi
AU  - Guzmán, Manuel
AU  - Lluís, Carmen
AU  - Alberch, Jordi
AU  - Canela, Enric I.
AU  - Ginés, Silvia
AU  - McCormick, Peter J.
PY  - 2020
DO  - 10.7554/eLife.51093
SN  - ESSN 2050-084X
UR  - https://hdl.handle.net/20.500.14352/6622
T2  - eLife
AB  - Early Huntington’s disease (HD) include over-activation of dopamine D1 receptors (D1R), producing an imbalance in dopaminergic neurotransmission and cell death. To reduce D1R over-activation, we present a strategy based on targeting complexes of D1R...
LA  - eng
M2  - 1
PB  - eLife Sciences Publications
KW  - Dopamine
KW  - Histamine
KW  - Huntington’s disease
TI  - Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington’sdisease
TY  - journal article
VL  - 9
ER  -